These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 22849581)
21. Current developments in intraspinal agents for cancer and noncancer pain. Lawson EF; Wallace MS Curr Pain Headache Rep; 2010 Feb; 14(1):8-16. PubMed ID: 20425209 [TBL] [Abstract][Full Text] [Related]
22. Intrathecal drug delivery for chronic pain management-scope, limitations and future. Czernicki M; Sinovich G; Mihaylov I; Nejad B; Kunnumpurath S; Kodumudi G; Vadivelu N J Clin Monit Comput; 2015 Apr; 29(2):241-9. PubMed ID: 25173564 [TBL] [Abstract][Full Text] [Related]
23. Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain. Sukul VV Neurosurg Clin N Am; 2019 Apr; 30(2):195-201. PubMed ID: 30898270 [TBL] [Abstract][Full Text] [Related]
24. Intrathecal Drug Delivery. De Andrés J; Rubio-Haro R; De Andres-Serrano C; Asensio-Samper JM; Fabregat-Cid G Methods Mol Biol; 2020; 2059():75-108. PubMed ID: 31435916 [TBL] [Abstract][Full Text] [Related]
26. Massive clonidine overdose during refill of an implanted drug delivery device for intrathecal analgesia: a review of inadvertent soft-tissue injection during implantable drug delivery device refills and its management. Johnson ML; Visser EJ; Goucke CR Pain Med; 2011 Jul; 12(7):1032-40. PubMed ID: 21672143 [TBL] [Abstract][Full Text] [Related]
27. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Patel VB; Manchikanti L; Singh V; Schultz DM; Hayek SM; Smith HS Pain Physician; 2009; 12(2):345-60. PubMed ID: 19305484 [TBL] [Abstract][Full Text] [Related]
28. Implantable intrathecal pumps for chronic pain: highlights and updates. Knight KH; Brand FM; Mchaourab AS; Veneziano G Croat Med J; 2007 Feb; 48(1):22-34. PubMed ID: 17309136 [TBL] [Abstract][Full Text] [Related]
29. Intrathecal drug delivery for pain: a clinical guide and future directions. Pope JE; Deer TR Pain Manag; 2015; 5(3):175-83. PubMed ID: 25971641 [TBL] [Abstract][Full Text] [Related]
30. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options. Deer TR; Pope JE; Hanes MC; McDowell GC Pain Med; 2019 Apr; 20(4):784-798. PubMed ID: 30137539 [TBL] [Abstract][Full Text] [Related]
31. Intrathecal analgesia. Cohen SP; Dragovich A Anesthesiol Clin; 2007 Dec; 25(4):863-82, viii. PubMed ID: 18054150 [TBL] [Abstract][Full Text] [Related]
32. History and present state of targeted intrathecal drug delivery. Rizvi S; Kumar K Curr Pain Headache Rep; 2015; 19(2):474. PubMed ID: 25638694 [TBL] [Abstract][Full Text] [Related]
33. The Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain. Deer TR; Hayek SM; Grider JS; Pope JE; Brogan SE; Gulati A; Hagedorn JM; Strand N; Hah J; Yaksh TL; Staats PS; Perruchoud C; Knezevic NN; Wallace MS; Pilitsis JG; Lamer TJ; Buchser E; Varshney V; Osborn J; Goel V; Simpson BA; Lopez JA; Dupoiron D; Saulino MF; McDowell GC; Piedimonte F; Levy RM Neuromodulation; 2024 Sep; ():. PubMed ID: 39297833 [TBL] [Abstract][Full Text] [Related]
34. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Deer TR; Smith HS; Cousins M; Doleys DM; Levy RM; Rathmell JP; Staats PS; Wallace M; Webster LR Pain Physician; 2010; 13(3):E175-213. PubMed ID: 20495597 [TBL] [Abstract][Full Text] [Related]
35. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients. Bolash R; Udeh B; Saweris Y; Guirguis M; Dalton JE; Makarova N; Mekhail N Neuromodulation; 2015 Feb; 18(2):150-5; discussion 155-6. PubMed ID: 25250852 [TBL] [Abstract][Full Text] [Related]
36. Management of a Cancer Patient with an Intrathecal Drug Delivery System and an Acute Brain Abscess. Walega DR; Korn M J Palliat Med; 2018 May; 21(5):727-729. PubMed ID: 29649397 [TBL] [Abstract][Full Text] [Related]
37. Retrospective Analysis of Intrathecal Drug Delivery: Outcomes, Efficacy, and Risk for Cancer-Related Pain at a High Volume Academic Medical Center. Sayed D; Monroe F; Orr WN; Phadnis M; Khan TW; Braun E; Manion S; Nicol A Neuromodulation; 2018 Oct; 21(7):660-663. PubMed ID: 29446171 [TBL] [Abstract][Full Text] [Related]
38. Refill Procedures of Intrathecal Drug Delivery Systems With a Recessed Fill Port on the Pump Surface: A Prospective Comparison Study of Ultrasound-Guided vs. Blind Refill Technique. Maino P; van Kuijk SMJ; Perez RSGM; Koetsier E Neuromodulation; 2019 Oct; 22(7):799-804. PubMed ID: 30238550 [TBL] [Abstract][Full Text] [Related]
39. Intrathecal Drug Delivery for Chronic Pain Syndromes: A Review of Considerations in Practice Management. Abd-Elsayed A; Karri J; Michael A; Bryce D; Sun J; Lee M; Orhurhu V; Deer T Pain Physician; 2020 Nov; 23(6):E591-E617. PubMed ID: 33185379 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of a Targeted Drug Delivery on-Demand Bolus Option for Chronic Pain. Bolash RB; Niazi T; Kumari M; Azer G; Mekhail N Pain Pract; 2018 Mar; 18(3):305-313. PubMed ID: 28520273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]